Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Immodulon Therapeutics Ltd
Federation Francophone de Cancerologie Digestive
OHSU Knight Cancer Institute
GSO Global Clinical Research BV
Fox Chase Cancer Center
Washington University School of Medicine
OHSU Knight Cancer Institute
Minneapolis Veterans Affairs Medical Center
NSABP Foundation Inc
AIO-Studien-gGmbH
European Organisation for Research and Treatment of Cancer - EORTC
AstraZeneca
Geriatric Oncology Consortium
Southwestern Regional Medical Center